A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.
Also called NCT07394114
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 240 participants
- Registry
-
NCT07394114
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07394114. Randomized; double masking; primary purpose treatment. Start 2026-02-24 (anticipated); primary completion 2027-08-28 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- HDM1005 1
- Intervention (Drug)
- HDM1005 2
- Intervention (Drug)
- HDM1005 injection or placebo
- Lead sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct07394114- Content hash
11f79a9c2af48120c8c8bc2922c17c22eb65c99456539b9a702c035cb909f9bb